NCT00948493View on ClinicalTrials.gov

Treatment Use of Generex Oral-lyn™ in Patients With Diabetes

NO_LONGER_AVAILABLEEXPANDED_ACCESS
Timeline

Start Date

Not specified

Conditions
Type 1 Diabetes MellitusType 2 Diabetes Mellitus
Interventions
DRUG

Buccal insulin spray

Oral insulin spray absorbed in buccal mucosa

Sponsors
All Listed Sponsors
lead

Generex Biotechnology Corp.

INDUSTRY

NCT00948493 - Treatment Use of Generex Oral-lyn™ in Patients With Diabetes | Biotech Hunter | Biotech Hunter